Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2021 | 2 |
2022 | 2 |
2023 | 1 |
2024 | 0 |
Search Results
4 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Did you mean
marcelino i
(28 results)?
Palliative Care Needs and Clinical Outcomes of Patients with Advanced Cancer in the Emergency Department.
J Palliat Med. 2022 Jul;25(7):1115-1121. doi: 10.1089/jpm.2021.0567. Epub 2022 May 13.
J Palliat Med. 2022.
PMID: 35559758
Free PMC article.
Does fintech lending expansion disturb financial system stability? Evidence from Indonesia.
Junarsin E, Pelawi RY, Kristanto J, Marcelin I, Pelawi JB.
Junarsin E, et al. Among authors: marcelin i.
Heliyon. 2023 Jul 18;9(9):e18384. doi: 10.1016/j.heliyon.2023.e18384. eCollection 2023 Sep.
Heliyon. 2023.
PMID: 37809948
Free PMC article.
Item in Clipboard
Observation unit use among patients with cancer following emergency department visits: Results of a multicenter prospective cohort from CONCERN.
Klotz AD, Caterino JM, Durham D, Felipe Rico J, Pallin DJ, Grudzen CR, McNaughton C, Marcelin I, Abar B, Adler D, Bastani A, Bernstein SL, Bischof JJ, Coyne CJ, Henning DJ, Hudson MF, Lyman GH, Madsen TE, Reyes-Gibby CC, Ryan RJ, Shapiro NI, Swor R, Thomas CR Jr, Venkat A, Wilson J, Jim Yeung SC, Yilmaz S, Stutman R, Baugh CW.
Klotz AD, et al. Among authors: marcelin i.
Acad Emerg Med. 2022 Feb;29(2):174-183. doi: 10.1111/acem.14392. Epub 2021 Dec 4.
Acad Emerg Med. 2022.
PMID: 34811858
Free PMC article.
Item in Clipboard
Standard dose raltegravir or efavirenz-based antiretroviral treatment for patients co-infected with HIV and tuberculosis (ANRS 12 300 Reflate TB 2): an open-label, non-inferiority, randomised, phase 3 trial.
De Castro N, Marcy O, Chazallon C, Messou E, Eholié S, N'takpe JB, Bhatt N, Khosa C, Timana Massango I, Laureillard D, Chau GD, Domergue A, Veloso V, Escada R, Wagner Cardoso S, Delaugerre C, Anglaret X, Molina JM, Grinsztejn B; ANRS 12300 Reflate TB2 study group.
De Castro N, et al.
Lancet Infect Dis. 2021 Jun;21(6):813-822. doi: 10.1016/S1473-3099(20)30869-0. Epub 2021 Mar 2.
Lancet Infect Dis. 2021.
PMID: 33667406
Clinical Trial.
Item in Clipboard
Cite
Cite